Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Israel - English - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: team excel distribution, inc. - carbamazepine - tablet - 200 mg

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: team excel distribution, inc. - felodipine - extended release tablet - 5 mg

Philippines - English - FDA (Food And Drug Administration)

rainbow life sciences private limited - india; importer: ambica international corporation; distributor: team excel distribution inc. - trimetazidine hydrochloride - film-coated tablet - 35mg

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: team excel distribution inc. - carvedilol - film-coated tablet - 25 mg

United States - English - NLM (National Library of Medicine)

raptor therapeutics inc. - cysteamine bitartrate (unii: qo84gz3tst) (cysteamine - unii:5ux2sd1ke2) - cysteamine 25 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 441.72 mg (equivalent: mercaptamine (cysteamine), qty 150 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 147.24 mg (equivalent: mercaptamine (cysteamine), qty 50 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

Canada - English - Health Canada

recordati rare diseases canada inc - cysteamine (cysteamine hydrochloride) - solution - 0.37% - cysteamine (cysteamine hydrochloride) 0.37% - eent drugs, miscellaneous